↓ Skip to main content

Precision Medicine in Chronic Rhinosinusitis with Nasal Polyps

Overview of attention for article published in Current Allergy and Asthma Reports, March 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
4 X users
patent
2 patents

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
102 Mendeley
Title
Precision Medicine in Chronic Rhinosinusitis with Nasal Polyps
Published in
Current Allergy and Asthma Reports, March 2018
DOI 10.1007/s11882-018-0776-8
Pubmed ID
Authors

Klementina Avdeeva, Wytske Fokkens

Abstract

Chronic rhinosinusitis is a disease with high prevalence, significant impact on health-related quality of life (HRQoL) and it is associated with substantial healthcare and productivity costs. We face an urgent need to improve the level of disease control and achieve higher patient satisfaction and disease prevention. Precision medicine is increasingly recognized as the way forward in optimal patient care. The combination of personalized care, prevention of disease, prediction of success of treatment, and participation of the patient in the elaboration of the treatment plan is expected to guarantee the best possible therapeutic approach for individuals suffering from a chronic disabling condition. This is a narrative review on the current state of endotypes, biomarkers, and targeted treatments in chronic inflammatory conditions of the nose and paranasal sinuses. Different phenotypes of rhinitis and chronic rhinosinusitis (CRS) have been described based on symptom severity and duration, atopy status, level of control, comorbidities, and presence or absence of nasal polyps in CRS. The underlying pathophysiological mechanisms are diverse, with different endotypes being recognized. Novel emerging therapies are targeting specific pathophysiological pathways or endotypes. This endotype-driven treatment approach requires careful selection of the patient population who might benefit from a specific treatment. This review provides a comprehensive overview of the current state of endotypes, biomarkers and targeted treatments in chronic inflammatory conditions of the nose and paranasal sinuses.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 102 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 13%
Student > Bachelor 10 10%
Other 8 8%
Student > Ph. D. Student 7 7%
Student > Master 7 7%
Other 18 18%
Unknown 39 38%
Readers by discipline Count As %
Medicine and Dentistry 41 40%
Biochemistry, Genetics and Molecular Biology 5 5%
Agricultural and Biological Sciences 4 4%
Nursing and Health Professions 2 2%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 5 5%
Unknown 43 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 February 2020.
All research outputs
#5,573,561
of 23,340,595 outputs
Outputs from Current Allergy and Asthma Reports
#213
of 814 outputs
Outputs of similar age
#96,012
of 332,188 outputs
Outputs of similar age from Current Allergy and Asthma Reports
#7
of 21 outputs
Altmetric has tracked 23,340,595 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 814 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 332,188 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.